Watson, R., Tong, O., Taylor, C., Kumar Sharma, P., Verge De Los Aires, A., Mahe, E., . . . Fairfax, B. (2021). Immune Checkpoint Blockade sensitivity and Progression-Free Survival associates with baseline CD8+ T cell clone size and cytotoxicity. bioRxiv.
Цитирование в стиле Чикаго (17-е изд.)Watson, R., et al. Immune Checkpoint Blockade Sensitivity and Progression-Free Survival Associates with Baseline CD8+ T Cell Clone Size and Cytotoxicity. bioRxiv, 2021.
Цитирование MLA (9-е изд.)Watson, R., et al. Immune Checkpoint Blockade Sensitivity and Progression-Free Survival Associates with Baseline CD8+ T Cell Clone Size and Cytotoxicity. bioRxiv, 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.